Industries › Healthcare › Biological Products, (No Diagnostic Substances)
Biological Products, (No Diagnostic Substances)
Market cap, price, and daily change for the 164 Biological Products, (No Diagnostic Substances) stocks we cover.
1–100 of 164
Page of 2
| AMGN | Amgen | 337.44 | -1.27% | $182.1B |
| GILD | Gilead Sciences | 123.63 | -1.46% | $153.5B |
| RVMD | Revolution Medicines, Inc. | 162.89 | +3.14% | $34.6B |
| BIIB | Biogen | 196.52 | -1.15% | $29.0B |
| MRNA | Moderna | 63.97 | +3.22% | $25.4B |
| NBIX | Neurocrine Biosciences Inc | 158.23 | -0.48% | $15.9B |
| EXEL | Exelixis, Inc. | 51.92 | -1.04% | $13.1B |
| KRYS | Krystal Biotech, Inc. | 347.56 | +1.68% | $10.2B |
| TECH | Bio-Techne | 57.95 | +5.36% | $9.1B |
| HALO | Halozyme Therapeutics, Inc. | 68.57 | -0.03% | $8.1B |
| IBRX | Immunitybio, Inc. | 7.34 | +5.01% | $7.7B |
| RGEN | Repligen Corp | 131.99 | -1.20% | $7.4B |
| KYMR | Kymera Therapeutics, Inc. | 90.37 | +0.44% | $7.4B |
| PCVX | Vaxcyte, Inc. | 51.44 | +1.57% | $7.4B |
| IMVT | Immunovant, Inc. | 35.27 | +1.75% | $7.2B |
| APGE | Apogee Therapeutics, Inc. | 90.43 | +2.28% | $6.8B |
| SRRK | Scholar Rock Holding Corp | 47.30 | +0.85% | $5.7B |
| TWST | Twist Bioscience Corp | 87.50 | +5.54% | $5.4B |
| CGON | Cg Oncology, Inc. | 61.08 | +1.18% | $5.4B |
| CRSP | Crispr Therapeutics Ag | 54.06 | +1.84% | $5.2B |
| DNLI | Denali Therapeutics Inc. | 23.27 | -0.92% | $3.7B |
| BEAM | Beam Therapeutics Inc. | 34.12 | +5.00% | $3.5B |
| RLAY | Relay Therapeutics, Inc. | 15.89 | +2.15% | $3.0B |
| ADPT | Adaptive Biotechnologies Corp | 17.54 | +4.47% | $2.8B |
| TARS | Tarsus Pharmaceuticals, Inc. | 63.16 | +1.04% | $2.7B |
| BCRX | Biocryst Pharmaceuticals Inc | 8.98 | +0.34% | $2.3B |
| KOD | Kodiak Sciences Inc. | 36.09 | +1.09% | $2.3B |
| VCEL | Vericel Corp | 40.11 | +2.35% | $2.0B |
| ADMA | Adma Biologics, Inc. | 8.29 | -1.43% | $1.9B |
| TSHA | Taysha Gene Therapies, Inc. | 6.40 | +3.39% | $1.8B |
| IOVA | Iovance Biotherapeutics, Inc. | 3.91 | -0.51% | $1.7B |
| RXRX | Recursion Pharmaceuticals, Inc. | 3.23 | +3.37% | $1.7B |
| GLUE | Monte Rosa Therapeutics, Inc. | 18.30 | -0.46% | $1.5B |
| VIR | Vir Biotechnology, Inc. | 9.15 | -1.66% | $1.5B |
| NVAX | Novavax Inc | 9.14 | -3.79% | $1.5B |
| MAZE | Maze Therapeutics, Inc. | 25.66 | +3.16% | $1.4B |
| COAG | Hemab Therapeutics Holdings, Inc. | 29.17 | +10.58% | $1.4B |
| INBX | Inhibrx Biosciences, Inc. | 92.75 | -1.49% | $1.4B |
| MGTX | Meiragtx Holdings Plc | 11.31 | +8.85% | $1.0B |
| CGEM | Cullinan Therapeutics, Inc. | 15.06 | +4.22% | $926M |
| ODTX | Odyssey Therapeutics, Inc. | 19.13 | +3.74% | $919M |
| SANA | Sana Biotechnology, Inc. | 3.15 | +3.96% | $877M |
| REPL | Replimune Group, Inc. | 10.15 | +3.78% | $838M |
| SLDB | Solid Biosciences Inc. | 8.40 | +14.91% | $827M |
| VOR | Vor Biopharma Inc. | 14.51 | -3.40% | $786M |
| ALLO | Allogene Therapeutics, Inc. | 1.99 | +1.53% | $687M |
| AURA | Aura Biosciences, Inc. | 6.33 | +0.16% | $654M |
| CADL | Candel Therapeutics, Inc. | 8.33 | +4.52% | $610M |
| PRME | Prime Medicine, Inc. | 3.23 | +2.38% | $583M |
| DNA | Ginkgo Bioworks Holdings, Inc. | 9.16 | +7.26% | $565M |
| TECX | Tectonic Therapeutic, Inc. | 29.86 | -0.78% | $564M |
| EIKN | Eikon Therapeutics, Inc. | 9.57 | -1.74% | $518M |
| FDMT | 4d Molecular Therapeutics, Inc. | 9.64 | +2.28% | $504M |
| STRO | Sutro Biopharma, Inc. | 29.68 | +4.05% | $492M |
| KYTX | Kyverna Therapeutics, Inc. | 8.06 | +0.50% | $490M |
| CABA | Cabaletta Bio, Inc. | 2.85 | +0.71% | $465M |
| CCCC | C4 Therapeutics, Inc. | 4.14 | +5.88% | $458M |
| OCGN | Ocugen, Inc. | 1.27 | +3.25% | $430M |
| LXEO | Lexeo Therapeutics, Inc. | 5.30 | +6.64% | $416M |
| IPSC | Century Therapeutics, Inc. | 2.27 | +1.11% | $410M |
| RGNX | Regenxbio Inc. | 7.79 | -1.33% | $403M |
| XFOR | X4 Pharmaceuticals, Inc | 4.20 | +3.70% | $396M |
| CMPX | Compass Therapeutics, Inc. | 2.03 | -0.98% | $366M |
| ZURA | Zura Bio Ltd | 3.74 | +3.03% | $355M |
| PALI | Palisade Bio, Inc. | 1.88 | +7.14% | $325M |
| LCTX | Lineage Cell Therapeutics, Inc. | 1.24 | +0.00% | $308M |
| SABS | SAB Biotherapeutics, Inc. | 4.00 | +4.17% | $306M |
| NMRA | Neumora Therapeutics, Inc. | 1.51 | +0.67% | $280M |
| IVVD | Invivyd, Inc. | 0.94 | +0.88% | $278M |
| SRZN | Surrozen, Inc./DE | 23.50 | -1.67% | $273M |
| EDIT | Editas Medicine, Inc. | 2.68 | +5.10% | $262M |
| AVXL | ANAVEX LIFE SCIENCES CORP. | 2.71 | +2.07% | $252M |
| ARTV | Artiva Biotherapeutics, Inc. | 9.79 | -0.81% | $242M |
| FATE | FATE THERAPEUTICS INC | 2.07 | +6.15% | $241M |
| IKT | Inhibikase Therapeutics, Inc. | 1.82 | +8.63% | $241M |
| CHRS | Coherus Oncology, Inc. | 1.47 | +6.52% | $227M |
| VYGR | Voyager Therapeutics, Inc. | 3.71 | +2.49% | $224M |
| TARA | Protara Therapeutics, Inc. | 3.98 | -1.97% | $223M |
| HUMA | Humacyte, Inc. | 0.92 | -5.63% | $203M |
| OTLK | Outlook Therapeutics, Inc. | 1.60 | -1.84% | $193M |
| ALEC | Alector, Inc. | 1.74 | +10.83% | $193M |
| LENZ | LENZ Therapeutics, Inc. | 6.15 | -2.54% | $193M |
| PLX | Protalix BioTherapeutics, Inc. | 2.21 | +9.41% | $178M |
| DTIL | PRECISION BIOSCIENCES INC | 6.79 | +4.55% | $175M |
| ABOS | Acumen Pharmaceuticals, Inc. | 2.27 | +0.89% | $164M |
| CRBU | Caribou Biosciences, Inc. | 1.64 | +0.00% | $163M |
| TNYA | Tenaya Therapeutics, Inc. | 0.73 | +2.62% | $158M |
| ACOG | Alpha Cognition Inc. | 6.89 | +5.35% | $150M |
| CGTX | COGNITION THERAPEUTICS INC | 1.45 | +2.12% | $129M |
| AGEN | AGENUS INC | 3.00 | +1.01% | $125M |
| TCRX | TScan Therapeutics, Inc. | 0.93 | +2.38% | $120M |
| ENGN | enGene Therapeutics Inc. | 1.72 | -1.99% | $115M |
| PROK | PROKIDNEY CORP. | 1.82 | +4.89% | $112M |
| KLRS | Kalaris Therapeutics, Inc. | 4.69 | +2.85% | $112M |
| ELOX | Eloxx Pharmaceuticals, Inc. | 13.50 | +4.41% | $102M |
| PTHS | Pelthos Therapeutics Inc. | 27.50 | +3.62% | $96M |
| BDTX | Black Diamond Therapeutics, Inc. | 1.65 | -0.90% | $95M |
| CSBR | CHAMPIONS ONCOLOGY, INC. | 6.71 | +5.75% | $93M |
| ATRA | Atara Biotherapeutics, Inc. | 10.05 | +4.25% | $91M |
| CRDF | Cardiff Oncology, Inc. | 1.21 | +2.54% | $83M |
Page of 2
Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices). Informational only — not financial advice.